ArticleCancer medicine2012

Soluble endothelial protein C receptor (sEPCR) is likely a biomarker of cancer-associated hypercoagulability in human hematologic malignancies.

Elodie Ducros et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.